^™middle.

Gathering signals...

Infratil (NZX:IFT) — Material Events

NZX:IFT · 3 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed

Major Score 90+

1

Infratil delivers 13.9% TSR with CDC contract and Longroad surge driving FY26 growthHigh

Infratil FY26 results show 10.5% EBITDAF growth, strong portfolio expansion, and upgraded credit rating

26 May 2026 ·Annual Results Presentation ·90

Significant Score 75–89

1

CDC Valuation Surges 23.6% to A$18.5 Billion on Capacity and Pipeline ExpansionMedium

CDC valuation rises 23.6% to A$18.5 billion driven by capacity growth and pipeline expansion

6 July 2026 ·Independent Valuation Update ·85

Notable Score 50–74

1

Infratil Issues 2.79 Million Shares Under Dividend Reinvestment Plan at NZD 14.70Medium

Infratil issues 2.79 million shares under Dividend Reinvestment Plan at NZD 14.70 each

29 June 2026 ·New Securities Quotation ·50

Not Assessed Low Score, or missing data

0

No articles in this tier for the last 12 months.

Market Mentions 2 - appeared in market wrap coverage

These are market wrap articles where Infratil (NZX:IFT) was mentioned. They reflect broader market coverage, not company-specific announcements.

Finance Wrap - Week 27 (29 June -> 3 July) 2026

Market Wrap - Week 22 (25 May -> 29 May) 2026